BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34105816)

  • 21. Biology of follicular lymphoma: insights and windows of clinical opportunity.
    Perrett M; Edmondson C; Okosun J
    Hematology Am Soc Hematol Educ Program; 2022 Dec; 2022(1):688-694. PubMed ID: 36485095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The follicular lymphoma epigenome regulates its microenvironment.
    Amin R; Braza MS
    J Exp Clin Cancer Res; 2022 Jan; 41(1):21. PubMed ID: 35022084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic Alterations Impact Immune Microenvironment Interactions in Follicular Lymphoma.
    Riether C; Ochsenbein AF
    Cancer Cell; 2020 May; 37(5):621-622. PubMed ID: 32396854
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenesis of follicular lymphoma: genetics to the microenvironment to clinical translation.
    Kumar E; Pickard L; Okosun J
    Br J Haematol; 2021 Sep; 194(5):810-821. PubMed ID: 33694181
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin S Alterations Induce a Tumor-Promoting Immune Microenvironment in Follicular Lymphoma.
    Bararia D; Hildebrand JA; Stolz S; Haebe S; Alig S; Trevisani CP; Osorio-Barrios F; Bartoschek MD; Mentz M; Pastore A; Gaitzsch E; Heide M; Jurinovic V; Rautter K; Gunawardana J; Sabdia MB; Szczepanowski M; Richter J; Klapper W; Louissaint A; Ludwig C; Bultmann S; Leonhardt H; Eustermann S; Hopfner KP; Hiddemann W; von Bergwelt-Baildon M; Steidl C; Kridel R; Tobin JWD; Gandhi MK; Weinstock DM; Schmidt-Supprian M; Sárosi MB; Rudelius M; Passerini V; Mautner J; Weigert O
    Cell Rep; 2020 May; 31(5):107522. PubMed ID: 32330423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
    Kastenschmidt JM; Schroers-Martin JG; Sworder BJ; Sureshchandra S; Khodadoust MS; Liu CL; Olsen M; Kurtz DM; Diehn M; Wagar LE; Alizadeh AA
    Cell Stem Cell; 2024 Mar; 31(3):410-420.e4. PubMed ID: 38402619
    [TBL] [Abstract][Full Text] [Related]  

  • 27. B-cell signaling networks reveal a negative prognostic human lymphoma cell subset that emerges during tumor progression.
    Irish JM; Myklebust JH; Alizadeh AA; Houot R; Sharman JP; Czerwinski DK; Nolan GP; Levy R
    Proc Natl Acad Sci U S A; 2010 Jul; 107(29):12747-54. PubMed ID: 20543139
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disruption of follicular dendritic cells-follicular lymphoma cross-talk by the pan-PI3K inhibitor BKM120 (Buparlisib).
    Matas-Céspedes A; Rodriguez V; Kalko SG; Vidal-Crespo A; Rosich L; Casserras T; Balsas P; Villamor N; Giné E; Campo E; Roué G; López-Guillermo A; Colomer D; Pérez-Galán P
    Clin Cancer Res; 2014 Jul; 20(13):3458-71. PubMed ID: 24799524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follicular lymphoma microenvironment: insights provided by single-cell analysis.
    Abe Y
    J Clin Exp Hematop; 2023 Sep; 63(3):143-151. PubMed ID: 37635086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional alteration of the lymphoma stromal cell niche by the cytokine context: role of indoleamine-2,3 dioxygenase.
    Maby-El Hajjami H; Amé-Thomas P; Pangault C; Tribut O; DeVos J; Jean R; Bescher N; Monvoisin C; Dulong J; Lamy T; Fest T; Tarte K
    Cancer Res; 2009 Apr; 69(7):3228-37. PubMed ID: 19276371
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The follicular lymphoma microenvironment: From tumor cell to host immunity.
    Martinez A; Carreras J; Campo E
    Curr Hematol Malig Rep; 2008 Oct; 3(4):179-86. PubMed ID: 20425464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenesis of follicular lymphoma.
    Lackraj T; Goswami R; Kridel R
    Best Pract Res Clin Haematol; 2018 Mar; 31(1):2-14. PubMed ID: 29452662
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutant EZH2 Induces a Pre-malignant Lymphoma Niche by Reprogramming the Immune Response.
    Béguelin W; Teater M; Meydan C; Hoehn KB; Phillip JM; Soshnev AA; Venturutti L; Rivas MA; Calvo-Fernández MT; Gutierrez J; Camarillo JM; Takata K; Tarte K; Kelleher NL; Steidl C; Mason CE; Elemento O; Allis CD; Kleinstein SH; Melnick AM
    Cancer Cell; 2020 May; 37(5):655-673.e11. PubMed ID: 32396861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Follicular programmed death 1-positive lymphocytes in the tumor microenvironment are an independent prognostic factor in follicular lymphoma.
    Richendollar BG; Pohlman B; Elson P; Hsi ED
    Hum Pathol; 2011 Apr; 42(4):552-7. PubMed ID: 21237493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A retrospective study of patients with follicular lymphoma (FL): identification of in situ FL or FL-like B cells of uncertain significance in lymph nodes resected at the time of previous surgery for carcinomas.
    Morita K; Nakamine H; Nakai T; Takano M; Takeda M; Enomoto Y; Yoshii Y; Kanno M; Ohbayashi C
    J Clin Pathol; 2015 Jul; 68(7):541-6. PubMed ID: 25862812
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can histologic transformation of follicular lymphoma be predicted and prevented?
    Kridel R; Sehn LH; Gascoyne RD
    Blood; 2017 Jul; 130(3):258-266. PubMed ID: 28408460
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chromatin modifying gene mutations in follicular lymphoma.
    Green MR
    Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathology, pathogenesis and molecular genetics of follicular NHL.
    Leich E; Ott G; Rosenwald A
    Best Pract Res Clin Haematol; 2011 Jun; 24(2):95-109. PubMed ID: 21658611
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mass Cytometry of Follicular Lymphoma Tumors Reveals Intrinsic Heterogeneity in Proteins Including HLA-DR and a Deficit in Nonmalignant Plasmablast and Germinal Center B-Cell Populations.
    Wogsland CE; Greenplate AR; Kolstad A; Myklebust JH; Irish JM; Huse K
    Cytometry B Clin Cytom; 2017 Jan; 92(1):79-87. PubMed ID: 27933753
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Duodenal-type and nodal follicular lymphomas differ by their immune microenvironment rather than their mutation profiles.
    Hellmuth JC; Louissaint A; Szczepanowski M; Haebe S; Pastore A; Alig S; Staiger AM; Hartmann S; Kridel R; Ducar MD; Koch P; Dreyling M; Hansmann ML; Ott G; Rosenwald A; Gascoyne RD; Weinstock DM; Hiddemann W; Klapper W; Weigert O
    Blood; 2018 Oct; 132(16):1695-1702. PubMed ID: 30126979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.